Hosted on MSN
The highly anticipated 'triple agonist' weight loss med is almost here—what doctors say about it
Eli Lilly just announced phase 3 clinical trial results for its new medication, retatrutide, and it could become the most effective weight loss medication yet. Retatrutide is a triple-agonist ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results